Noile-Immune Biotech Inc.
Noile-Immune Biotech Inc. scores highest on Torque (55) and lowest on Nitro (9). Its PosiPenta is 30.82 out of 100, weaker than most similar companies.
On the Penta Grid this week, Noile-Immune Biotech Inc. is Grid #51 of 53 in the Healthcare sector in Japan, and Grid #1,003 of 1,059 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Noile-Immune Biotech Inc. | 30.82 | 36 | 12 | 9 | 55 | 41 |
| Kohjin Bio Co., Ltd. | 34.55 | 54 | 39 | 9 | 36 | 36 |
| AIAI Group Corporation | 49.19 | 82 | 63 | 15 | 46 | 40 |
| GIMIC Co., Ltd. | 50.57 | 80 | 58 | 12 | 72 | 31 |
| Hi-CRATES CO.,LTD. | 68.48 | 80 | 55 | 65 | 83 | 60 |
| PRISM BioLab Co.,LTD | 23.97 | 13 | 16 | 17 | 53 | 21 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.05 |
| P/B ratio | 1.07 |
EEarnings
| Trailing EPS | ₹-10.54 |
| Forward EPS | ₹-17.56 |
NNitro
| Price | 53.27 |
| 52-week high | 131.36 |
| 52-week low | 51.46 |
| Fall from 52-week high | 59.4% |
TTorque
| Return on equity (ROE) | -19.12% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.30 |
| Market cap | ₹231 Cr |
| Insider holding | 54.55% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Noile-Immune Biotech Inc.'s PosiPenta score?
Noile-Immune Biotech Inc.'s PosiPenta is 30.82 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Noile-Immune Biotech Inc. stand on the Penta Grid?
On the Penta Grid this week, Noile-Immune Biotech Inc. is Grid #51 of 53 in the Healthcare sector in Japan, and Grid #1,003 of 1,059 in Japan.
Which PosiPenta pillar is strongest for Noile-Immune Biotech Inc.?
Torque (durability), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Noile-Immune Biotech Inc.?
Nitro (momentum), with a score of 9 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.